POINT–COUNTERPOINT: What is the optimal trial design to test hyperthermia for carcinoma of the cervix? POINT: Addition of hyperthermia or cisplatin to radiotherapy for patients with cervical cancer; two promising combinations—no definite conclusions.
Saved in:
| Title: | POINT–COUNTERPOINT: What is the optimal trial design to test hyperthermia for carcinoma of the cervix? POINT: Addition of hyperthermia or cisplatin to radiotherapy for patients with cervical cancer; two promising combinations—no definite conclusions. |
|---|---|
| Authors: | Van Der Zee, J., Koper, P. C. M., Lutgens, L. C. H. W., Burger, C. W. |
| Source: | International Journal of Hyperthermia. Jan/Feb2002, Vol. 18 Issue 1, p19-24. 6p. 1 Chart. |
| Database: | Academic Search Ultimate |
| ISSN: | 02656736 |
|---|---|
| DOI: | 10.1080/02656730110083738 |
